No abstract available
Publication types
-
Practice Guideline
-
Review
MeSH terms
-
Algorithms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Aromatase Inhibitors / therapeutic use
-
Breast / radiation effects
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Breast Neoplasms / therapy*
-
Combined Modality Therapy
-
Female
-
Humans
-
Lymphatic Metastasis
-
Mastectomy
-
Neoadjuvant Therapy
-
Neoplasm Invasiveness
-
Neoplasm Recurrence, Local / prevention & control
-
Neoplasm Staging
-
Neoplasms, Hormone-Dependent / drug therapy
-
Neoplasms, Hormone-Dependent / metabolism
-
Postmenopause
-
Premenopause
-
Randomized Controlled Trials as Topic
-
Receptor, ErbB-2 / metabolism
-
Selective Estrogen Receptor Modulators / therapeutic use
-
Sentinel Lymph Node Biopsy
-
Tamoxifen / therapeutic use
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Aromatase Inhibitors
-
Selective Estrogen Receptor Modulators
-
Tamoxifen
-
Receptor, ErbB-2
-
Trastuzumab